ECCO would like to thank all of the ECCO2017 Ambassadors for their work.
Riccardo A. Audisio
Riccardo A. Audisio completed his medical studies in Padua where he specialised in general surgery and diagnostic radiology. Upon completion of his training at the National Cancer Institute of Milan, Dr. Audisio was appointed Deputy Director of the Department of General Surgery, European Institute of Oncology (Milan). Dr. Audisio is currently an Honorary Senior Lecturer of Molecular and Clinical Cancer Medicine at the University of Liverpool, in addition to Consultant Breast Surgeon at St Helens Teaching Hospital.
Dr. Audisio’s clinical research focuses on breast cancer and geriatric oncology. He has peer reviewed over 200 publications in addition to authoring over 35 book chapters. A frequent contributor to international scientific journals, Dr. Audisio is currently the Editor-in-Chief of the European Journal of Surgical Oncology, in addition to member of several international societies including BASO, ESSO, ESMO, and SIOG. He is Past-President of both BASO and ESSO, and has served as an advisor to the Department of Health and to the All Party Parliamentary Group on Breast Cancer in Older Women.
Ahmad Awada studied medicine at the Université Libre de Bruxelles (ULB), Belgium. Following a specialisation in internal medicine and medical oncology from the Jules Bordet Institute, Dr. Awada completed research fellowships at the New Drug Development Office, Free University (Amsterdam) and at the Institute for Drug Development (San Antonio), where he focused on the clinical development of new anticancer agents. Dr. Awada has previously held the positions of Assistant Head of Medical Oncology Clinic and Head of the New Drugs Development Unit at Jules Bordet Institute, and is currently the Head of the Medical Oncology Clinic and Associate Head of the Department of Medicine.
With a focus on the treatment of solid tumors, particularly in breast cancer, Dr. Awada has been an active contributor to the development of new drugs, including cytotoxics, molecular-targeted therapies and immunotherapies. He is also an active member of several international scientific societies (ASCO, EORTC and ESMO), and has published over 250 articles in international publications.
Maria João Cardoso
Maria João Cardoso completed her undergraduate and postgraduate studies at the Porto Faculty of Medicine. Dr. Cardoso has dedicated her career to breast surgery and completed her training in oncoplastic surgery at the Institute Gustave Roussy in France. Her PhD studies focused on the objective evaluation of aesthetic results in breast cancer conservative treatment. Dr. Cardoso has previously held the positions of Clinical Director at the S. João Hospital Breast Unit in Porto and was Assistant Professor of the Department of Surgery at the Porto Faculty of Medicine. As of 2011, she is the Head Breast Surgeon at the Champalimaud Cancer Centre Breast Unit.
Dr. Cardoso has published more than 20 papers in international journals and has contributed to over 80 other communications in major international conferences. She is also a member of the editorial board of The Breast journal and a reviewer of several international journals. With a primary focus on the quality of life of breast cancer patients, Dr. Cardoso founded a support centre for breast cancer patients called Mama Help in 2011. She is also a member of the board of the Portuguese Society of Senology.
Peter Dubsky completed his medical studies at the University of Vienna and began his surgical training at the University Clinic. Upon completion of a post-doctoral fellowship in cancer immunology at the Baylor Institute for Immunology Research, he received his board certification in general surgery in 2005. With a focus on surgical oncology, Dr. Dubsky was promoted to Senior Consultant at the Medical University of Vienna in 2007. He is currently an Associate Professor with a clinical and scientific focus on breast cancer.
At the Medical University of Vienna, Dr. Dubsky is involved with the Vienna Breast Health Care Center Executive Committee, is coordinator of the Vienna Comprehensive Cancer Center biomarker cluster and the Multidisciplinary Breast Cancer Tumor Board. Dr. Dubsky is also a member of the certification commission that reviews Austria’s breast cancer centres, and holds elected positions in the Austrian Breast and Colorectal Cancer Study Group (ABCSG) Executive Committee and the Breast Intergroup (BIG) Advisory Council. He has also authored over 50 scientific publications and has given numerous lectures globally.
Elitsa Encheva completed her medical studies in the Faculty of Medicine, Medical University-Sofia. She also holds a Master’s degree in Public Health and Health Management from the same institution. Dr. Encheva fulfilled her residency requirements in the Department of Radiotherapy, National Oncology Centre – Sofia and at the Department of Radiotherapy, University Hospital “Queen Giovanna”. She has held the position of Assistant Professor, Department of Imaging and Radiotherapy, Medical University-Varna and is currently the Associate Professor. Dr. Encheva is also the Head of the Radiotherapy Department at the University Hospital “Saint Marina” – Varna.
Dr. Encheva’s research focuses on normal tissue radiosensitivity, genetic basis of radiosensitivity, the recording and scoring of normal tissue morbidity, gynaecological cancer, gastrointestinal tumours, CNS tumours, Chemoradition, reirradiation, SRS and imaging in oncology and radiotherapy. She has published 49 articles in national and international journals, and is a member of the Guild of Bulgarian Radiotherapists, the Bulgarian Association of Radiology and ESTRO.
Jesper Grau Eriksen
Jesper Grau Eriksen studied medicine at the University of Southern Denmark, specialising in head and neck oncology. In addition to consultancy work in clinical oncology, Dr. Eriksen is currently an Associate Professor at the Department of Oncology, Odense University Hospital. His research interests include the predictive and prognostic markers of radiotherapy, in addition to patterns of failure after radiotherapy for head and neck carcinoma.
Dr. Eriksen is a member of ETC, the Chair of the UEMS section of Radiation Oncology and Radiotherapy, as well as member of the FALCON and DOVE taskforces. He is also involved with ESTRO, DSHHO, SSHNO, UEMS, DSKO and DSCR.
Alain Fourquet earned his medical qualifications from the Faculty of Medicine Necker, Université Paris V, and completed a residency at the Institute Curie, Hôpital Necker. In addition, Dr. Fourquet was a fellow at the Memorial Sloan-Kettering Cancer Center and is currently the Head of the Department of Oncology Radiotherapy at the Institute Curie. Dr. Fourquet’s research focuses on clinical breast cancer, with special interest to technical improvements in the delivery of breast irradiation, ductal carcinoma in situ, and the study of long-term outcomes after treatment and its consequences.
Dr. Fourquet is an active member of the European Society of Radiation Oncology, the American Society of Radiation Oncology, EORTC, and the Société Française de Sénologie et de Pathologie Mammaire. He has published over 230 peer reviewed articles, as well as book chapters, reviews and abstracts. In addition, Dr. Fourquet was the Chairman of the 7th European Breast Cancer Conference.
Cai Grau received his Doctor of Medical Science from the University of Aarhus. Dr. Grau specialises in clinical and experimental radiation oncology and medical physics, in addition to head and neck oncology. He has completed a research fellowship at the Vancouver Cancer Center, and medical rotations at the Aarhus University Hospital and the Viborg County Hospital. Dr. Grau is currently a Senior Staff Member and Professor at the Department of Oncology at the Aarhus University Hospital, in addition to the Chairman of the ESTRO task-force on Health Economics in Radiation Oncology (HERO). He is also the Co-Director at the Lundbeck Foundation Center for Interventional Research in Radiation Oncology (CIRRO).
Dr. Grau has published more than 150 peer-reviewed works and has delivered over 170 scientific meeting presentations. He is a member of the Danish Medical Research Council and has been awarded the Oncology Award from the Danish Society for Clinical Oncology.
Jana Jaal specialised in radiology at Dresden Technical University and studied medicine at the University of Tartu. Her research interests include the prevention and treatment of malignant tumours, with special interest in lung cancer and central nervous system tumours. She has previously held advisory positions in the ministries of Health and Social Affairs for the Republic of Estonia, in addition to the position of Chairman of the Board of the Estonian Society of Clinical Oncologists. Dr. Jaal is the Head of Clinic, Associate Professor of Oncology and Senior Research Fellow in Oncology at the University of Tartu.
Complementing her research interests, Dr. Jaal has been a speaker for various international conferences and forums. She is the recipient of the EDRO Prize from the European Society for Radiotherapy and Oncology, and the ESTRO/VRIAN Research Award from the European Society for Radiotherapy and Oncology. Dr. Jaal is an active contributor to scholarly articles with involvement in over 20 publications.
Jacek Jassem received his Doctor of Medicine from the University of Gdańsk. He trained in oncology at the Karolinska Institute (Stockholm) and the National Cancer Institute (Amsterdam). Dr. Jassem is currently a Professor of Clinical Oncology and Radiotherapy and Head of the Department at the Medical University of Gdańsk. His scientific interests include lung cancer, breast cancer, combined modality treatment with chemotherapy and radiation, in addition to molecular oncology.
Dr. Jassem has previously held the positions of Chairman of the EORTC Breast Cancer Group, the EORTC Executive Committee, Chairman of the Central and Eastern European Oncology Group, Chairman of the ASCO International Affairs Committee and is the immediate Past-President of the Polish Oncological Society. He is a current member of the European Academy of Cancer Sciences and the Polish Academy of Art and Sciences. Dr. Jassem also serves as an ESMO Executive Board Member. He has produced over 1600 academic publications and has contributed to several radio and TV programmes. Dr. Jassem has also undertaken nationwide public health initiatives, including the authoring of Polish anti-tobacco legislation and the coordination of the Cancer Control Strategy for Poland.
Ulrich Keilholz completed his medical studies at the University of Mainz and at the University of Heidelberg. Dr. Keilholz has previously held the position of Deputy Director of the Charité Comprehensive Cancer Centre (Berlin), and since 2013, has been the Acting Director. He is also the Past-Vice President and President of the International Society for Biological Therapy of Cancer. He has participated in many phase I/II and III clinical trials, and has spearheaded more than 20 trials covering various disease entities in hematology and medical oncology, with special focus on head and neck cancer, in addition to melanoma.
Dr. Keilholz is a member of EORTC, the American Society for Clinical Oncology, AIO and DGHO. He is an ESMO faculty member (Principles of Clinical Trials and Systemic Therapy, Melanoma, Tumour Immunology and Immunotherapy) and was an ESMO National Representative. Dr. Keilholz is part of the Editorial Board of several journals which include the Journal of Clinical Oncology, Melanoma Research and the Journal of Translational Medicine.
Pedro C. Lara
Pedro C. Lara obtained his PhD from the University of Grenada following positions as a research fellow and a residency in the Oncology Department of the Granada University Hospital. Dr. Lara then worked as Consultant and Associate Professor of Oncology at the University Hospital of Las Palmas. He has worked with the European Cancer Centre Fellowship Programme, which aimed to develop translational oncology research at the Netherlands Cancer Institute. Dr. Lara is currently the Director of the Canarian Institute for Cancer Research Foundation, in addition to Head of the Department of Radiation Oncology in Las Palmas University Hospital.
Dr. Lara is a member of the editorial board of several scientific journals, and is involved with numerous professional societies, including the Spanish Association for Cancer Research, the European Association for Cancer Research, ESTRO, ASTRO and EORTC. He is also the President of the Spanish Society for Radiation Oncology and Secretariat of the Spanish Society for Clinical Oncology.
Siniša Maksimović received his medical degree from the Faculty of Medicine at the University of Belgrade. He specialises in all aspects of surgical oncology, with expertise in liver and bile duct tumours, the management of advanced and complex abdominal malignancies, in addition to colorectal cancer and abdominal sarcomas. Dr. Maksimović is currently a Professor of Surgery, and is the Director of “Sveti Vračevi” Hospital.
Dr. Maksimović is a member of various local and international associations of surgeons and surgical oncologists including the Society of Surgical Oncology, the American Society of Surgery and the American College of Surgeons. He has contributed more than 200 academic publications and has been instrumental in educational courses at both graduate and post graduate levels.
Svilen Maslyankov completed his medical degree and received a specialisation in general surgery from the Medical University of Sofia. His expertise lies in advanced laparoscopic and minimally invasive surgery. Dr. Maslyankov is currently a specialist in general surgery and surgical oncology at the Department of Surgery at the Medical University of Sofia.
Dr. Maslyankov is a member of the European Society of Coloproctology, the European Society of Surgical Oncology and the Balkan Union of Oncology, to name a few. He has contributed immensely to medical academia, including literature on contemporary trends in the treatment of rectal cancer and the application of colonic pouch in the operative treatment of rectum carcinoma.
Niall O’Higgins completed his medical studies at the University College Dublin and received his surgical training in Ireland and England, specifically at the Royal Postgraduate Medical Centre, London. He was appointed to the positions of Professor and Chair of the University College Dublin Department of Surgery, in addition to Consultant Surgeon at St Vincent’s University Hospital. Contributing to over 300 scientific publications, Dr. O’Higgins focuses on surgical oncology, with special interest in breast cancer.
Dr. O’Higgins is the recipient of the Honorary Fellowship of the Royal College of Surgeons of England and of the American College of Surgeons. He has also received the President’s Gold Medal of the Royal College of Surgeons of Edinburgh and is an Honorary Member of ESSO. Nail O’Higgins is the former President of the Royal College of Surgeons in Ireland, of the European Society of Surgical Oncology and the Federation of European Cancer Societies. In line with his research interests, Dr. O’Higgins has worked extensively in establishing a system of breast cancer services and in BreastCheck, the National Breast Cancer Screening Service.
Piotr Rutkowski earned his Doctor of Medicine from the Medical University of Lodz, and following his residency, he completed the general surgery board at the Medical University of Poland. Dr. Rutkowski then obtained his specialty in surgical oncology at Maria Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology where he currently works in the Department of Soft Tissue/Bone Sarcoma and Melanoma. His scientific activities focus on sarcoma research, GIST and melanoma. Dr. Rutkowski has participated in several investigator-driven trails in sarcoma and melanoma and is a member of the steering committee of the CAMN107A2201 GIST trial.
In addition to being the Coordinator of the Polish Clinical GIST Registry, Dr. Rutkowski is a reviewer for the European Journal of Surgical Oncology and the World Journal of Surgical Oncology. He is an active participant of several Polish and international societies, a prominent member of the EORTC Soft Tissue and Bone Sarcoma Group and the EORTC Melanoma Group. Dr. Rutkowski is currently working closely with national patients’ advocacy groups for GIST and sarcoma.
Peter Selby earned a Natural Sciences degree at the University of Cambridge and completed his medical and oncological training at Kings College Hospital, University College Hospital, the Royal Marsden Hospital, the Princess Margaret Hospital and the Ontario Cancer Institute. He was also a clinical research fellow at the Institute for Cancer Research and Royal Marsden where he became a Consultant and Senior Lecturer. Dr. Selby’s early research predominantly focused on haematological malignancies, stem cell biology, bone marrow transplantation and antiviral therapy. His current clinical focus is in biotherapy and clinical cancer proteomics to identify biomarkers and new targets for cancer therapy.
As the Director of the National Cancer Research Network, Dr. Selby established cancer research networks which were successful in increasing clinical trail activity in the UK. His efforts have substantially influenced developments in domestic and international health care. Dr. Selby was appointed Fellow of the Academy of Medical Sciences and was awarded a CBE for his services to cancer research and care. In 2007, he became President of the Association of Cancer Physicians and has won the Pfizer Excellence in Oncology Lifetime Achievement award. Dr. Selby is currently the Director of the Leeds Biomedical and Health Research Centre and the Director of the Leeds Institute of Molecular Medicine.
Yauheni Shlyakhtunou studied at the “Vitebsk State Medical University, the Order of Friendship”, Republic of Belarus. He was a graduate student of the Department of Oncology with a focus on radiation diagnosis and radiotherapy. With a specialisation in surgical oncology, Dr. Shlyakhtunou is currently working in the Department of Oncology, teaching courses in radiation and radiotherapy. In addition, he works in the regional oncological clinic and university hospital.
Dr. Shlyakhtunou has written more than 60 scientific publications and over 20 educational works. He is also the author of 4 patents for invention, 2 rationalisation proposals and 2 instructions for use. Dr. Shlyakhtunou is the recipient of several awards including the second prize of the Special Fund of the President of the Republic of Belarus to support gifted students, the President of the Republic of Belarus postgraduate scholarship and the President of the Republic of Belarus Scholarship for young scientists. He is an active member of ESMO and ASCO.
Cora N. Sternberg
Cora N. Sternberg is a graduate of the University of Pennsylvania, and is currently the Chief of the Department of Medical Oncology at the San Camillo-Forlanini Hospital and Adjunct Professor at La Sapienza University (Rome). She is also the Adjunct Professor of Urology and Urological Oncology at Tufts University School of Medicine, the Lahey Clinic (Boston) and Temple University’s College of Science and Technology (Pennsylvania).
Dr. Sternberg has been involved in various international medical organisations including ESMO and ECCO. She has also been the Scientific Coordinator of many international symposia including the European Kidney Cancer Association and the ECCO-ESMO-ESTRO meeting in September 2013. Dr. Sternberg is especially known for her contributions to bladder cancer, her publications on targeted agents in renal cell carcinoma and innovative therapies for prostate cancer. She is also the Founder of the Samuel and Barbara Sternberg Cancer Research Foundation (ONLUS), which raises funds to support cancer care and research at the San Camillo Forlanini Hospital.
Malin Sund completed her medical degree at the University of Oulu and later spent time as a post-doctoral fellow at Harvard Medical School. Dr. Sund is currently a Professor of Surgery at the University of Oulu, in addition to her position as a surgical specialist at the University Hospital of Umea.
She is the recipient of the Royal Skyttean community prize for young researchers, and the Swedish Surgical Society major research prize. In 2012, Dr. Sund was elected to the post of Lennander lecturer at the Swedish Society of Medicine and she is also a Member of the Board of the Swedish Association of Breast Surgery.
Maksim Barmotska is affiliated with the N.N. Alexandrov National Cancer Centre of Belarus and has completed the CECOG fellowship at the Comprehensive Cancer Centre (CCC) in the General Hospital of Vienna.
Eka Dgebuadze is a medical oncologist at the Tbilisi Cancer Centre in Georgia.
PRINT THIS PAGE
Page last modified: